Skandinaviska Enskilda Banken AB (publ) - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 231 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,188
+1.5%
43,600
-17.1%
0.01%0.0%
Q2 2023$1,170
-49.1%
52,600
-50.4%
0.01%
-50.0%
Q1 2023$2,298
-99.6%
106,100
+365.4%
0.02%
+300.0%
Q1 2021$542,000
-22.3%
22,800
-14.6%
0.00%
-20.0%
Q4 2020$698,000
-61.4%
26,700
-74.3%
0.01%
-61.5%
Q3 2020$1,808,000
+49.9%
103,900
+44.9%
0.01%
+30.0%
Q2 2020$1,206,00071,7000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders